PMID- 37268011 OWN - NLM STAT- MEDLINE DCOM- 20231116 LR - 20231122 IS - 1439-3646 (Electronic) IS - 0947-7349 (Linking) VI - 131 IP - 11 DP - 2023 Nov TI - Aerobic Training Increases Hippocampal Volume and Protects Cognitive Function for Type 2 Diabetes Patients with Normal Cognition. PG - 605-614 LID - 10.1055/a-2105-0799 [doi] AB - AIM: To evaluate the effects of aerobic training on hippocampal volume and cognitive function in patients with type 2 diabetes mellitus (T2DM) with normal cognition. MATERIALS AND METHODS: One hundred patients with T2DM aged 60-75 years who met inclusion criteria were randomized into the aerobic training group (n=50) and control group (n=50). The aerobic training group received 1 year of aerobic training, while the control group maintained their lifestyle without additional exercise intervention. The primary outcomes were hippocampal volume measured by MRI and Mini-mental State Examination (MMSE) score or Montreal Cognitive Assessment scale (MoCA) scores. RESULTS: Eighty-two participants completed the study (aerobic training group, n=40; control group, n=42). There was no significant difference between the two groups at baseline (P>0.05). After one year of moderate aerobic training, increase in total and right hippocampal volume in the aerobic training group were significantly higher than in the control group (P=0.027, P=0.043, respectively). In the aerobic group, total hippocampal volume significantly increased after the intervention compared with baseline (P=0.034). The between-group difference in the change of MMSE and MoCA scores was statistically significant (P=0.015, P=0.027, respectively). Logistic regression showed strong correlations between aerobic training and increase in total hippocampal volume (OR:1.091, [95%CI 0.969, 1.228], P=0.002), improvement of MMSE scores (OR:1.127, [95%CI 1.005, 1.263], P=0.041) or MoCA scores (OR:2.564, [95%CI 2.098.2.973], P=0.045). CONCLUSIONS: One-year moderate aerobic training increased total and right hippocampal volume and protected cognitive function for T2DM patients with normal cognition. Early intervention focusing on cognition protection should be considered for T2DM patients in clinical settings. CI - Thieme. All rights reserved. FAU - Wang, Ying AU - Wang Y AD - The First Affiliated Hospital of Hainan Medical University, Hainan Clinical Research Center for Metabolic Disease, Haikou, Hainan Province, China. FAU - Wang, Liping AU - Wang L AD - Department of Geriatrics, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China. FAU - Yan, Juan AU - Yan J AD - Jiangsu college of nursing, Huaian, Jiangsu Province, China. FAU - Yuan, Xiaodan AU - Yuan X AD - Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, University of Chinese Medicine, Nanjing, Jiangsu Province, China. FAU - Lou, Qing Q AU - Lou QQ AD - The First Affiliated Hospital of Hainan Medical University, Hainan Clinical Research Center for Metabolic Disease, Haikou, Hainan Province, China. LA - eng SI - ClinicalTrials.gov/NCT04489966 GR - (2014-WSN-025)/the Six Talent Peaks Project/ PT - Clinical Trial PT - Randomized Controlled Trial DEP - 20230602 PL - Germany TA - Exp Clin Endocrinol Diabetes JT - Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association JID - 9505926 SB - IM MH - Humans MH - *Diabetes Mellitus, Type 2/complications/therapy MH - Cognition MH - Exercise MH - Magnetic Resonance Imaging MH - Hippocampus/diagnostic imaging MH - *Cognitive Dysfunction MH - Neuropsychological Tests COIS- The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. EDAT- 2023/06/03 11:42 MHDA- 2023/11/16 06:45 CRDT- 2023/06/02 19:13 PHST- 2023/11/16 06:45 [medline] PHST- 2023/06/03 11:42 [pubmed] PHST- 2023/06/02 19:13 [entrez] AID - 10.1055/a-2105-0799 [doi] PST - ppublish SO - Exp Clin Endocrinol Diabetes. 2023 Nov;131(11):605-614. doi: 10.1055/a-2105-0799. Epub 2023 Jun 2.